I've fully extracted the textbook. Here are comprehensive, exam-ready answers for all your questions:
CHAPTER 1 - INFECTIVE ENDOCARDITIS
Q: Name three bacteria causing infective endocarditis
- Staphylococcus aureus - most common overall cause; causes acute IE
- Viridans streptococci (e.g., S. sanguinis) - most common cause of subacute bacterial endocarditis (SBE)
- Enterococcus - common in IV drug users and elderly; associated with left-sided IE
(Others include: CoNS, HACEK group, Streptococcus gallolyticus)
Q: HACEK agents
HACEK is an abbreviation for a group of highly fastidious, slow-growing, capnophilic, gram-negative bacteria that reside in the oral cavity as commensals but occasionally cause bacterial endocarditis.
Members:
- H - Haemophilus parainfluenzae
- A - Aggregatibacter species (A. actinomycetemcomitans, A. aphrophilus, A. paraphrophilus)
- C - Cardiobacterium hominis
- E - Eikenella corrodens
- K - Kingella kingae
Key features:
- Account for ~5% of total IE cases
- Typically has a subacute course
- Occurs in patients with pre-existing valvular defects or those undergoing dental procedures
- Aortic and mitral valves most commonly affected
- They are capnophilic (optimal growth in presence of 5-10% CO2)
- Require prolonged incubation (up to 1 week)
Lab Diagnosis:
- Blood cultures on automated systems (e.g., BacT/ALERT)
- Identification by automated systems (MALDI-TOF)
- Molecular methods: broad-range bacterial PCR targeting 16S rRNA gene followed by sequencing
Treatment: Ceftriaxone 4g/day for 4 weeks (drug of choice); quinolones if beta-lactamase producer
Q: Rheumatic Fever - Disease mechanism / Diagnosis
Definition: Acute Rheumatic Fever (ARF) is a multisystem disease that occurs in people previously affected with Group A Streptococcus (S. pyogenes) sore throat, as a result of an autoimmune reaction.
Pathogenesis (Disease Mechanism):
- Precipitating infection: ARF follows upper respiratory tract infection with Group A streptococci (M serotypes 1, 3, 5, 6, 14, 18, 24)
- Genetic predisposition: HLA-DR2 and HLA-DR4 confer susceptibility
- Autoimmune/Molecular Mimicry theory: Antibodies targeted against streptococcal antigens (M protein) cross-react with human tissue antigens (heart, joints)
- These cross-reactive antibodies bind to valvular endothelium, leading to damage to heart valves
- Results in Rheumatic Heart Disease (RHD) with chronic valvular damage
Clinical Manifestations (Major Jones Criteria):
- Carditis (pancarditis affecting endocardium, pericardium, myocardium)
- Migratory polyarthritis - most common manifestation; joints become hot, swollen, red, tender; moves from one joint to another
- Chorea (Sydenham's chorea) - involuntary movement disorder affecting head and limbs
- Erythema marginatum - pink macular rashes that appear and disappear
- Subcutaneous nodules - painless, small mobile lumps beneath skin over bony prominences
Diagnosis - Revised Jones Criteria (2015):
Major Criteria (Low-risk population):
- Carditis (clinical or subclinical)
- Polyarthritis only
- Chorea, Erythema marginatum, Subcutaneous nodules
Major Criteria (High-risk population):
- Carditis, Monoarthritis or polyarthritis, Polyarthralgia, Chorea, Erythema marginatum, Subcutaneous nodules
Minor Criteria:
- Polyarthralgia (low-risk), Monoarthralgia (high-risk)
- Hyperpyrexia (≥38.5°C)
- ESR ≥60 mm/h and/or CRP ≥3 mg/dL
- Prolonged PR interval on ECG
Diagnostic Criteria:
- Initial ARF: Two major OR one major + two minor criteria
- Evidence of preceding streptococcal infection: rising ASO titre or positive throat culture
Treatment: Penicillin (oral penicillin V or amoxicillin for 10 days, or IM single dose of 1.2 million units benzathine penicillin G). Aspirin for arthritis/arthralgia/fever.
Secondary Prophylaxis: IM benzathine penicillin G every 3-4 weeks
- ARF without carditis: 5 years or till age 21 (whichever longer)
- ARF with carditis but no residual valvular disease: 10 years or age 21
- ARF with persistent valvular disease: 10 years or age 40 (sometimes lifelong)
CHAPTER 2 - ANEMIA (BLOODSTREAM INFECTIONS)
Q: Blood culture - methods and indications
Indications:
- Bacteremia or fungemia (suspected)
- Infective endocarditis
- Pyrexia of unknown origin (PUO)
- Septicemia/sepsis
- Typhoid and paratyphoid fever
- Brucellosis
- Meningitis
- Immunocompromised patients with fever
- Neonatal sepsis
Methods of Blood Culture:
1. Conventional/Manual Method:
- Blood collected aseptically by venipuncture
- Two blood culture sets should be collected at an interval of 1 hour between 1st and 2nd set
- Alternatively, 3 or more blood culture sets can be collected over a 24-hour period
- A blood culture set = blood from single venipuncture divided into two bottles (aerobic + anaerobic)
- Volume: 8-10 mL per bottle in adults; 1-3 mL in children
- Blood:broth ratio = 1:5 to 1:10 (dilutes inhibitory substances in blood)
- Incubated at 37°C
2. Automated Blood Culture Systems (BacT/ALERT, BACTEC):
- Most widely used modern method
- Continuously monitors CO2 production by bacteria using fluorescent or colorimetric sensors
- Flags positive bottles automatically
- Most sensitive and faster than conventional methods
3. Biphasic Blood Culture (Castaneda method):
- A single bottle with both solid and liquid media
- Liquid medium covers the solid agar slope
- Bottle is tilted periodically to spread liquid over solid medium
- Advantage: dual detection, fewer subcultures needed
- Used for: Brucella, leptospira
4. Clot Culture:
- Blood is collected without anticoagulant; allowed to clot
- Clot is washed and cultured
- Advantage: concentrates organisms (intracellular) in leukocytes
- Used for: Salmonella typhi (higher yield than broth culture in some studies), Brucella
5. Lysis Centrifugation (Isolator system):
- Blood is lysed using saponin; centrifuged to concentrate organisms
- Pellet is plated onto solid media
- Best method for fungi and mycobacteria
Processing:
- Gram stain from flagged positive bottles
- Subculture onto blood agar, chocolate agar, MacConkey agar
- Sensitivity testing of isolates
Q: Pyrexia of Unknown Origin (PUO) - Etiology
Definition (Petersdorf and Beeson): Fever >38.3°C (101°F) on several occasions over more than 3 weeks with no diagnosis after 1 week of inpatient investigation.
Etiology (classified):
1. Infections (Most common cause, ~30-40%):
- Bacterial: Tuberculosis (most common infectious cause), infective endocarditis, brucellosis, typhoid, abscess (intra-abdominal, hepatic, pelvic)
- Viral: EBV (infectious mononucleosis), CMV, HIV
- Parasitic: Visceral leishmaniasis (kala-azar), malaria
- Fungal: Histoplasmosis, candidiasis
2. Neoplasms (~20-30%):
- Lymphoma (Hodgkin's and Non-Hodgkin's)
- Leukemia
- Renal cell carcinoma (hypernephroma)
- Hepatocellular carcinoma
- Other solid tumors
3. Connective Tissue / Autoimmune Disorders (~15-20%):
- Adult Still's disease (most common in young adults)
- Systemic lupus erythematosus (SLE)
- Rheumatoid arthritis
- Polyarteritis nodosa, Giant cell arteritis (in elderly)
4. Miscellaneous (~15%):
- Drug fever
- Inflammatory bowel disease
- Sarcoidosis
- Factitious fever
5. Undiagnosed (~10-15%)
Q: Clot Culture
Definition: A method of blood culture where blood is collected WITHOUT anticoagulant, allowed to clot, and the clot is then cultured.
Principle: During clotting, bacteria (especially intracellular organisms within leukocytes) become concentrated in the clot. When the clot is lysed and cultured, higher bacterial yield is obtained.
Procedure:
- Collect 5-10 mL blood without anticoagulant into a sterile tube
- Allow to clot at room temperature
- Serum is separated (can be used for serology)
- Clot is washed with sterile saline to remove RBCs
- Clot is emulsified/digested with streptokinase or SPS (sodium polyanethol sulfonate)
- The lysate is inoculated into culture media
Advantages:
- Concentrates organisms (useful for intracellular pathogens)
- Higher yield for Salmonella typhi compared to broth cultures in the second and third weeks of typhoid fever
- The separated serum can simultaneously be used for Widal test
Uses:
- Typhoid fever (weeks 2-3)
- Brucellosis
- Leptospirosis
Q: Name three blood-borne viral infections
- HIV (Human Immunodeficiency Virus) - causes AIDS
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
Others: Hepatitis D virus, HTLV-1, Ebola/Marburg viruses, Dengue virus, CMV (in immunocompromised)
Q: Common microbial agents (parasites) causing anemia and type of anemia
| Parasite | Type of Anemia |
|---|
| Plasmodium falciparum (malaria) | Hemolytic anemia (destruction of RBCs); also dilutional anemia |
| Plasmodium vivax | Hemolytic anemia |
| Leishmania donovani (kala-azar) | Normocytic normochromic anemia (due to hypersplenism, bone marrow infiltration) |
| Trypanosoma spp. | Hemolytic anemia |
| Hookworm (Ancylostoma, Necator) | Iron deficiency anemia (microcytic hypochromic) - blood loss from GI tract |
| Diphyllobothrium latum (fish tapeworm) | Megaloblastic anemia (Vit B12 deficiency) |
| Babesia spp. | Hemolytic anemia |
CHAPTER 3 - ENTERIC FEVER
Q: Typhoid fever - pathogenesis and laboratory diagnosis
Causative Agent:
Salmonella typhi (Typhoid fever) and S. paratyphi A, B, C (Paratyphoid fever)
Pathogenesis:
1. Ingestion: S. typhi is ingested via contaminated food/water (fecal-oral route). Infective dose = 10^5 organisms.
2. Penetration of intestinal mucosa: Bacteria penetrate the small intestinal mucosa (mainly ileum) through M cells (microfold cells) overlying Peyer's patches. Bacteria are taken up by macrophages in the lamina propria.
3. Primary bacteremia (1st bacteremia): Bacteria travel via lymphatics to mesenteric lymph nodes, then through the thoracic duct into the bloodstream - causing 1st (primary) bacteremia (asymptomatic/prodrome phase; lasts ~10 days).
4. Intracellular multiplication: Bacteria multiply inside macrophages in the reticuloendothelial system (liver, spleen, bone marrow, lymph nodes) - this corresponds to the incubation period (10-14 days).
5. Secondary bacteremia (sustained/2nd bacteremia): Bacteria re-enter the bloodstream causing 2nd (secondary/sustained) bacteremia - this marks the onset of clinical illness (fever, headache, malaise).
6. Intestinal complications (3rd week): Bacteria re-invade the intestine through the gallbladder bile. Peyer's patches become hyperplastic and undergo necrosis, leading to:
- Intestinal hemorrhage
- Intestinal perforation (most serious complication)
Clinical stages:
- Week 1: Fever (stepladder pattern), headache, abdominal pain, constipation (early), rose spots on abdomen
- Week 2: High fever, splenomegaly, relative bradycardia (Faget sign), hepatomegaly
- Week 3: Complications (perforation, hemorrhage)
- Week 4: Defervescence, recovery
Laboratory Diagnosis:
1. Blood Culture (Gold standard):
- Week 1-2: BEST specimen - blood culture (sensitivity ~80% in week 1)
- Positive in 80-90% cases in 1st week
- Clot culture can also be used
- Automated systems (BacT/ALERT, BACTEC) or conventional
2. Bone Marrow Culture:
- Most sensitive method (90-95% positivity even after antibiotic therapy)
- Positive throughout the disease
- Especially useful in partially treated cases
3. Widal Test (Serological):
- Detects agglutinating antibodies against O antigen (somatic) and H antigen (flagellar)
- Significant titre: O antigen ≥1:80 (>1:160 in endemic areas), H antigen ≥1:160
- 4-fold rise in titre between acute and convalescent sera is significant
- Performed from 2nd week onwards (antibodies appear after 1 week)
- Limitation: false positives in endemic areas, cross-reactions, prior vaccination
4. Stool Culture:
- Positive from 2nd-3rd week and in carriers
- Best specimen for detecting chronic carriers
5. Urine Culture:
- Positive from 3rd-4th week in ~25% cases
6. Typhidot Test (Dot-EIA/ELISA):
- Detects IgM and IgG antibodies against 50 kDa outer membrane protein (OMP) of S. typhi
- IgM positive = current infection
- IgG positive = past infection
- More sensitive and specific than Widal
7. Typhidot-M: Detects only IgM; eliminates false positive IgG due to prior exposure
8. TUBEX test:
- Detects IgM antibodies to O9 antigen of S. typhi
- Rapid test, result in 2 minutes
9. Molecular methods: PCR (nested PCR targeting flagellin gene, 16S rRNA gene)
10. Newer methods: Blood culture with VITEK-2, MALDI-TOF
Q: Widal Test - Uses and Interpretations
Principle: Widal test is a tube agglutination test (or slide agglutination) that detects agglutinating antibodies (IgM initially, then IgG) against O (somatic) and H (flagellar) antigens of Salmonella typhi and paratyphi.
Antigens used:
- S. typhi O (somatic/LPS antigen)
- S. typhi H (flagellar antigen)
- S. paratyphi A H antigen
- S. paratyphi B H antigen
Uses:
- Serodiagnosis of typhoid and paratyphoid fever
- Helps when blood culture is negative (e.g., partially treated cases)
- Epidemiological surveys
Interpretation:
- Single titre: O antibody ≥1:80 (or >1:160 in endemic areas) is significant; H antibody ≥1:160 is significant
- Most significant: 4-fold or greater rise in antibody titre in paired sera (acute + convalescent, 2 weeks apart)
- O antibodies rise first (appear by end of 1st week), reach peak by 3rd-4th week, and disappear within months
- H antibodies rise later, persist for years, and may indicate past infection or vaccination
Type of agglutination:
- O agglutination: granular, compact clumps (somatic)
- H agglutination: floccular, fluffy, cotton-wool-like clumps (flagellar)
Limitations / Causes of false positive:
- Previous typhoid vaccination (raises H antibody)
- Prior exposure in endemic areas
- Cross-reactions with other Salmonella serotypes or Enterobacteriaceae (Brucella, Yersinia)
- Other fevers (malaria, dengue, liver disease)
Causes of false negative:
- Early infection (antibodies not yet risen)
- Partially treated patients
- Immunocompromised hosts
- Some strains may not stimulate antibody production
Q: Methods to detect carriers of typhoid fever
Definition of carrier: A person who continues to harbor S. typhi after clinical recovery and can transmit infection.
- Temporary/convalescent carrier: <3 months after illness
- Chronic carrier: >1 year (usually in gallbladder/bile duct; chronic cholecystitis)
- Contact/healthy carrier: No history of illness
Methods to detect carriers:
1. Stool Culture:
- Most important method
- Multiple stool cultures (at least 3) should be performed
- S. typhi is excreted in stool for prolonged periods
2. Urine Culture:
- Less sensitive
- Occasionally positive in chronic carriers
3. Bile/Duodenal aspirate Culture:
- Direct sampling from duodenum via duodenal string test (Enterotest)
- Higher sensitivity than stool culture for biliary carriers
- The string capsule is swallowed, and after 4-6 hours the string is retrieved and cultured
4. Widal test:
- Less useful for carrier detection; H antibody may be high in vaccinated persons
- Vi antibody: Detection of antibodies against Vi (virulence) antigen - high Vi antibody titre (≥1:20) suggests chronic carrier state. Vi test is more specific for carrier detection.
5. Vi Agglutination Test:
- High Vi antibody titre indicates a chronic carrier
- Used as a screening test before stool culture
Q: Prophylaxis of Enteric Fever
Non-specific / General Measures:
- Safe water supply (chlorination, boiling)
- Proper sewage disposal
- Food safety and hygiene
- Hand washing
- Detection and treatment of carriers (especially food handlers)
- Fly control
Specific (Vaccines):
- Ty21a (oral live attenuated vaccine)
- Vi polysaccharide vaccine (Vi CPS)
- TAB vaccine (killed whole cell vaccine) - now largely replaced
- Typhoid conjugate vaccine (TCV) - Vi antigen conjugated to tetanus toxoid; recommended by WHO for children
Q: Typhoid Vaccines (TAB Vaccine)
TAB vaccine stands for Typhoid-A-B vaccine.
Composition:
- Heat-killed, phenol-preserved whole cells of:
- Salmonella typhi (T)
- Salmonella paratyphi A (A)
- Salmonella paratyphi B (B)
Type: Killed whole-cell vaccine
Route: Subcutaneous (SC)
Dosage: Two doses given 4-6 weeks apart; booster every 3 years
Efficacy: About 70-80% protective (only against typhoid, not paratyphoid despite inclusion)
Side effects: Local pain, swelling, systemic fever and malaise (due to LPS of killed bacteria)
Current status: Largely replaced by newer vaccines (Vi CPS and Ty21a) due to:
- Significant side effects
- Poor immunogenicity for paratyphoid component
Modern Typhoid Vaccines:
1. Vi CPS (Vi polysaccharide vaccine - Typhim Vi, Typherix):
- Contains purified Vi capsular polysaccharide
- SC or IM injection, single dose
- Protects for 2-3 years
- Not effective in children <2 years (T-independent antigen)
- Efficacy: ~70%
2. Ty21a (Vivotif - oral live attenuated vaccine):
- Attenuated mutant of S. typhi (lacks Vi antigen, galE mutant)
- 3 oral doses on alternate days
- Efficacy: ~70% for 5-7 years
- Contraindicated in immunocompromised
3. Typhoid Conjugate Vaccine (TCV - Typbar-TCV):
- Vi polysaccharide conjugated to tetanus toxoid carrier protein
- Single IM injection
- Effective in children >6 months
- Provides T-cell dependent immunity; longer protection (>2 years)
- Recommended by WHO (2018) for endemic countries
CHAPTER 4 - RICKETTSIAL INFECTIONS
Q: Epidemic Typhus
Causative agent: Rickettsia prowazekii
Vector: Human body louse (Pediculus humanus corporis) - classic vector
- Man is the reservoir; louse becomes infected by feeding on a rickettsiemic patient
- Louse feces containing rickettsiae are deposited on skin; infection occurs by scratching the bite site (rubbing louse feces into the wound)
Epidemiology:
- Occurs in conditions of overcrowding, poor hygiene, war, famine, disaster situations
- Worldwide but mainly in mountainous regions of Africa, South America, Asia
Clinical Features:
- Incubation period: 1-2 weeks
- Sudden onset of high fever (up to 40°C), severe headache, myalgia
- Maculopapular rash appears on 4th-6th day, starting on trunk and spreading centrifugally (spares face, palms, soles)
- Progressive obtundation, delirium, coma in severe cases
- Complications: myocarditis, pneumonia, renal failure, DIC
Brill-Zinsser Disease: Recrudescent epidemic typhus - reactivation of latent R. prowazekii years/decades after primary infection; milder illness
Lab Diagnosis:
- Weil-Felix test: OX-19 and OX-2 agglutinate; OX-K negative
- Complement fixation test (CFT)
- Indirect fluorescent antibody (IFA) - gold standard
- PCR
- Giemsa or immunofluorescence staining of tissue/skin biopsy
Treatment: Doxycycline (drug of choice); chloramphenicol is alternative
Q: Weil-Felix Test (Reaction)
Principle: The Weil-Felix test is an heterophile agglutination test based on the cross-reactivity between antigens of certain Rickettsia species and antigens of certain Proteus strains (OX-2, OX-19, OX-K strains of Proteus vulgaris and P. mirabilis).
Basis of cross-reactivity: Some Rickettsia share common polysaccharide (somatic O) antigens with Proteus OX strains.
Antigens used:
- Proteus OX-19 - agglutinated by antibodies against R. rickettsii, R. prowazekii, R. typhi
- Proteus OX-2 - agglutinated by antibodies against R. rickettsii, R. conorii
- Proteus OX-K - agglutinated by antibodies against Orientia tsutsugamushi (scrub typhus)
Interpretation:
| Disease | OX-19 | OX-2 | OX-K |
|---|
| Epidemic typhus (R. prowazekii) | +++ | + | - |
| Murine/Endemic typhus (R. typhi) | +++ | + | - |
| Rocky Mountain Spotted Fever (R. rickettsii) | ++ | ++ | - |
| Scrub typhus (O. tsutsugamushi) | - | - | +++ |
| Q fever (Coxiella burnetii) | - | - | - |
Limitations:
- Low sensitivity and specificity
- False positives: UTI due to Proteus, Borrelia, leptospirosis, brucellosis, liver disease
- Q fever and Rickettsialpox give NEGATIVE results (no cross-reactivity)
- Currently replaced by more specific tests (IFA, ELISA)
- Considered a screening test only
Q: Scrub Typhus
Causative agent: Orientia tsutsugamushi (formerly Rickettsia tsutsugamushi)
Vector/Host: Trombiculid mites (chiggers) - larval stage (Leptotrombidium deliense - most important species)
- Mites are both vectors AND reservoir (transovarial transmission in mites)
- Humans are accidental dead-end hosts
Geographic distribution: "Tsutsugamushi triangle" - Japan, Southeast Asia, Indian subcontinent, northern Australia; endemic in India (Himalayan foothills, Rajasthan, Tamil Nadu)
Transmission: Bite of infected chigger larvae
Pathogenesis: Invades endothelial cells; causes vasculitis
Clinical Features:
- Incubation: 6-21 days
- Eschar (tache noire): Painless black eschar at site of chigger bite - pathognomonic
- High fever, headache, myalgia
- Lymphadenopathy (especially regional near eschar)
- Maculopapular rash on trunk (4th-5th day), spreads to limbs
- Hepatosplenomegaly
- Complications: pneumonitis, meningitis, myocarditis, ARDS
Lab Diagnosis:
- Weil-Felix test: OX-K positive (OX-19 and OX-2 negative)
- IFA (gold standard) - titre ≥1:200 diagnostic
- Rapid diagnostic tests (ICT)
- PCR
- Giemsa staining of peripheral blood smear - intracytoplasmic organisms in monocytes
- Isolation in L929 cell line (BSL-3 required)
Treatment: Doxycycline 100 mg BD for 7-15 days; azithromycin in pregnancy/children
Q: Q Fever
Causative agent: Coxiella burnetii - a pleomorphic gram-negative intracellular organism. Taxonomically, now classified as a member of Legionellales. Forms a spore-like small cell variant (SCV) that is extremely resistant to heat, drying, and chemical disinfectants.
Transmission:
- NOT transmitted by arthropod vector (unlike other rickettsiae)
- Inhalation of infected dust/aerosols from parturient animals (cattle, sheep, goats) - most common route
- Contact with infected birth products (placenta, amniotic fluid)
- Ingestion of unpasteurized milk
- Rarely: tick bite (Dermacentor, Amblyomma)
Reservoir: Cattle, sheep, goats; also ticks
Clinical Features:
- Acute Q fever: Fever, headache, myalgia, hepatitis (granulomatous), atypical pneumonia (like a "flu-like illness")
- Chronic Q fever (Endocarditis): Most serious complication; occurs months-years later; mainly involves pre-existing abnormal/prosthetic valves; culture-negative endocarditis
Lab Diagnosis:
- Weil-Felix test is NEGATIVE (no cross-reactivity with Proteus OX antigens)
- Phase variation: C. burnetii exists in two phases:
- Phase I: Virulent form (from naturally infected animals); smooth LPS
- Phase II: Avirulent form (in laboratory passage); rough LPS
- Serology (IFA - gold standard):
- Acute Q fever: Phase II IgG/IgM antibodies predominate
- Chronic Q fever/Endocarditis: Phase I IgG ≥1:800 highly suggestive
- PCR (blood, tissue)
- Culture (BSL-3): not routine
- Modified Duke criteria: Single positive blood culture or Phase I IgG antibody titre ≥1:800 = major criterion for IE
Treatment: Doxycycline (acute); Doxycycline + hydroxychloroquine for 18-36 months (chronic endocarditis)
CHAPTER 5 - MISCELLANEOUS BACTERIAL BLOODSTREAM INFECTIONS
Q: Spirochaetes of medical importance - diseases, pathogenicity and lab diagnosis of Leptospirosis (Weil's disease)
Spirochaetes of Medical Importance:
| Genus | Species | Disease |
|---|
| Treponema | T. pallidum subsp. pallidum | Syphilis |
| T. pallidum subsp. pertenue | Yaws |
| T. pallidum subsp. carateum | Pinta |
| T. vincenti | Vincent's angina |
| Borrelia | B. recurrentis | Louse-borne relapsing fever |
| B. duttoni | Tick-borne relapsing fever |
| B. burgdorferi | Lyme disease |
| Leptospira | L. interrogans | Leptospirosis (Weil's disease) |
Leptospirosis (Weil's Disease):
Causative agent: Leptospira interrogans (pathogenic species) with multiple serovars; Serovar icterohaemorrhagiae (carried by rats) causes the most severe form - Weil's disease.
Morphology:
- Tightly coiled, thin, flexible spirochaetes
- 6-20 µm long, 0.1 µm wide
- Hooked ends (characteristically bent at one or both ends like a question mark)
- Motile by axial filaments (periplasmic flagella)
- Cannot be seen by Gram stain; visible by dark-field microscopy
Reservoir and Transmission:
- Reservoir: Wild and domestic animals (rats most important; also cattle, dogs, pigs)
- Transmission: Contact with water/soil contaminated with urine of infected animals (leptospires excreted in urine)
- Entry: Through skin abrasions or mucous membranes (conjunctiva, oral)
- Occupational risk: Farmers, sewer workers, veterinarians, miners, military personnel
- Recreational risk: Swimming in contaminated water
Pathogenesis:
- Entry through skin/mucous membrane → leptospiraemia (1st week)
- Dissemination to all organs via blood
- Vasculitis (endothelial damage) is the key mechanism
- Target organs: Liver, kidneys, lungs, meninges
- Immune phase (2nd week): Antibodies appear, organisms cleared from blood but persist in kidneys
Clinical Features:
- Anicteric leptospirosis (90% cases): Mild; biphasic fever
- Phase I (Leptospiraemic): High fever, myalgia (severe, especially calf muscles - pathognomonic), headache, conjunctival suffusion (redness without discharge), nausea, vomiting. Lasts 3-7 days.
- Phase II (Immune/Leptospiruric): Fever recurs; meningismus; leptospiruria begins
- Weil's Disease (5-10% cases - severe icteric leptospirosis):
- Jaundice (hepatic involvement)
- Renal failure (acute tubular necrosis) - oliguria/anuria
- Hemorrhagic manifestations (epistaxis, hemoptysis, thrombocytopenia)
- Myocarditis
- Mortalitiy: 5-15% in Weil's disease
Laboratory Diagnosis:
Specimen selection depends on phase:
- Week 1 (leptospiraemic phase): Blood, CSF
- Week 2 onwards (immune/leptospiruric phase): Urine
1. Direct Microscopy:
- Dark-field microscopy of blood (week 1) or urine (week 2)
- Leptospires appear as bright, coiled, motile organisms against dark background
- Silver staining of tissue sections
2. Culture:
- EMJH (Ellinghausen-McCullough-Johnson-Harris) medium or Fletcher's semi-solid medium
- Incubated at 28-30°C for up to 6 weeks
- Blood culture: Week 1; Urine culture: Week 2 onwards
- Very slow-growing; results take weeks
3. Serology:
- MAT (Microscopic Agglutination Test) - GOLD STANDARD
- Live leptospiral antigens mixed with patient serum
- Agglutination seen under dark-field microscopy
- Titre ≥1:100 in clinical context, or 4-fold rise in paired sera is diagnostic
- Can identify the specific serovar
- ELISA: Detects IgM antibodies; used for rapid screening
- Rapid dipstick/ICT tests: Detect leptospiral antibodies
4. PCR:
- Most sensitive in early leptospiraemic phase
- Can detect leptospiral DNA in blood, urine, CSF
5. Immunofluorescence: Direct FA on blood/urine/tissue
Treatment: Mild - oral doxycycline; Severe (Weil's disease) - IV penicillin G or ceftriaxone
Q: Brucellosis - clinical features and laboratory diagnosis (Undulant fever / Human brucellosis)
Causative agents:
- B. melitensis (goats, sheep) - most virulent, most common cause in India
- B. abortus (cattle)
- B. suis (pigs)
- B. canis (dogs)
Transmission:
- Ingestion of unpasteurized milk/dairy products from infected animals
- Direct contact with infected animal products (abortus material, carcasses) - occupational risk
- Inhalation of aerosols in abattoir workers
- NOT person-to-person (rare exceptions)
Pathogenesis:
- Brucella is a facultative intracellular organism
- Survives inside macrophages by inhibiting phagolysosomal fusion
- Spreads to lymph nodes → bloodstream → RES (liver, spleen, bone marrow, lymph nodes)
- Granuloma formation in infected tissues
Clinical Features:
Acute brucellosis (<8 weeks):
- Insidious onset of fever
- Undulant fever: Characteristic relapsing, remitting fever pattern (rises in evening, subsides in morning with drenching sweats)
- Severe malaise, weakness, myalgia, arthralgia
- Headache
- Splenomegaly, hepatomegaly, lymphadenopathy
Subacute (8 weeks-1 year):
- Continued fever, weight loss, constitutional symptoms
Chronic brucellosis (>1 year):
- Localized complications: Spondylitis (Brucella spondylitis - lumbar spine most common), sacroiliitis, peripheral arthritis, orchitis/epididymitis, endocarditis (severe, culture-negative), neurobrucellosis
Laboratory Diagnosis:
1. Blood Culture (Definitive):
- Isolation of Brucella from blood, bone marrow, or other tissues is gold standard
- Bone marrow culture: Most sensitive (85-90%)
- Blood culture: Positive in 50-80%
- Culture requires prolonged incubation (up to 6 weeks at 37°C)
- Growth in CO2 (especially B. abortus)
- Biphasic (Castaneda) medium preferred
- Automated systems (BACTEC, BacT/ALERT)
- CAUTION: Brucella is a BSL-3 organism; lab must be alerted
2. Serology:
- Serum Agglutination Test (SAT)/Wright's agglutination test:
- Single titre ≥1:160 significant; 4-fold rise in paired sera diagnostic
- Titre >1:320 with compatible clinical features = probable brucellosis
- Detects IgM (prozone effect possible at high titres - use dilutions)
- Rose Bengal Plate Test (RBPT):
- Rapid, simple screening test
- Uses buffered acid antigen of B. abortus
- High sensitivity, used for screening
- ELISA: More sensitive; detects IgM, IgG, IgA
- 2-Mercaptoethanol (2-ME) test:
- 2-ME destroys IgM, leaving only IgG agglutination
- Persistent IgG (post 2-ME agglutination ≥1:160) = current/chronic infection
- Differentiates acute (high IgM) from chronic (IgG dominant) infection
- Coombs test: Detects incomplete (non-agglutinating) antibodies in chronic brucellosis
3. PCR:
- Highly sensitive and specific
- Can detect Brucella DNA from blood, bone marrow, other specimens
4. Microscopy:
- Gram-negative small coccobacilli (may need 10× objective as they are very faint)
- Modified Ziehl-Neelsen stain: Brucella stains pink against blue background (partially acid-fast)
Treatment: Doxycycline + Rifampicin for 6 weeks; severe cases: Doxycycline + Gentamicin
CHAPTER 6 - HIV/AIDS
Q: Enumerate STDs. Morphology, pathogenesis, lab diagnosis of HIV. Opportunistic infections. Prophylaxis.
Sexually Transmitted Diseases (STDs):
Bacterial STDs:
- Syphilis (Treponema pallidum)
- Gonorrhea (Neisseria gonorrhoeae)
- Chlamydia (Chlamydia trachomatis)
- Chancroid (Haemophilus ducreyi)
- Lymphogranuloma venereum (LGV) (C. trachomatis L1-L3)
- Granuloma inguinale/Donovanosis (Klebsiella granulomatis)
- Mycoplasma genitalium
Viral STDs:
- HIV/AIDS
- Herpes simplex virus type 2 (HSV-2) - genital herpes
- Human Papillomavirus (HPV) - genital warts, cervical cancer
- Hepatitis B, C
- Molluscum contagiosum (MCV)
Parasitic STDs:
- Trichomoniasis (Trichomonas vaginalis)
- Pubic lice (Phthirus pubis)
- Scabies (Sarcoptes scabiei)
Structure/Morphology of HIV:
HIV is a retrovirus belonging to family Retroviridae, genus Lentivirus.
Morphology:
- Spherical, enveloped virus, ~100-120 nm diameter
Structure (from outside to inside):
-
Envelope (lipid bilayer): Derived from host cell membrane during budding
- Contains gp120 (surface glycoprotein/knobs) - binds to CD4 receptors
- gp41 (transmembrane glycoprotein) - mediates fusion with host cell
- Together form gp160 precursor (cleaved by host protease)
-
Matrix protein (p17/MA): Lines inner surface of envelope; stabilizes the virion
-
Capsid (p24/CA): Conical/truncated cone-shaped core; contains:
- Two copies of positive-sense single-stranded RNA genome (+ssRNA)
- Reverse transcriptase (RT/p66/p51) - RNA-dependent DNA polymerase
- Integrase (p32/IN) - integrates proviral DNA into host genome
- Protease (p10) - cleaves polyprotein precursors
-
Nucleocapsid (p7/NC): Surrounds and protects RNA
Genome: 9.8 kb ssRNA (+sense); contains:
- Structural genes: gag (p17, p24, p7), pol (RT, integrase, protease), env (gp120, gp41)
- Regulatory genes: tat, rev (essential)
- Accessory genes: vif, vpr, vpu/vpx, nef
Antigens of HIV:
- Core antigens: p24 (most important - detected in ELISA/4th generation tests), p17, p7
- Envelope antigens: gp120, gp41, gp160
- Pol antigens: p66, p51 (RT), p32 (integrase), p10 (protease)
Pathogenesis of HIV Infection:
1. Entry into host:
- HIV binds via gp120 to CD4 receptor (on CD4+ T lymphocytes, macrophages, dendritic cells)
- Co-receptors required: CCR5 (for macrophage-tropic, R5 strains - early infection) or CXCR4 (for T-cell tropic, X4 strains - late infection)
- gp41 mediates fusion; viral core enters cytoplasm
2. Reverse transcription:
- HIV reverse transcriptase converts ssRNA → double-stranded DNA (dsDNA)
- Error-prone process → generates genetic diversity/mutations (drug resistance)
3. Integration:
- Viral dsDNA is transported to nucleus
- Integrase integrates viral DNA into host chromosome → forms provirus
- Provirus can remain latent indefinitely
4. Viral replication:
- Activated CD4+ cells transcribe proviral DNA → viral RNA
- Tat protein: transactivator, dramatically increases transcription
- Rev protein: facilitates transport of viral RNA from nucleus
- Viral proteins assembled; protease cleaves polyproteins into functional units
- New virions bud from cell membrane
5. CD4+ T-cell depletion:
- Direct killing by viral budding
- Apoptosis of infected and uninfected CD4+ cells
- Immune destruction of HIV-infected cells
- Normal CD4 count: 500-1500 cells/µL
- When CD4 <500: Symptomatic HIV
- When CD4 <200: AIDS-defining (opportunistic infections occur)
6. Stages of HIV infection:
- Acute HIV syndrome (Primary HIV infection): 2-4 weeks after exposure; flu-like illness (fever, lymphadenopathy, rash, pharyngitis); high viral load, transient drop in CD4+
- Clinical latency (asymptomatic): 8-10 years average; gradual CD4 decline; virus still replicating
- AIDS: CD4 <200/µL or AIDS-defining condition
Laboratory Diagnosis of HIV:
NACO Guidelines for HIV diagnosis in India:
1. Enzyme-Linked Immunosorbent Assay (ELISA):
- Screening test
- 4th generation ELISA (HIV Combo test) detects:
- Anti-HIV 1 + 2 antibodies (IgM + IgG)
- p24 antigen (core antigen - detects acute infection before antibody development)
- Reduces window period to ~15 days
2. Rapid Tests (point-of-care):
- Immunochromatographic tests
- Results in 30 minutes
- NACO strategy: Three rapid tests (Strategy III)
NACO Strategy III (for diagnosis):
- Test 1 (A1): Most sensitive ELISA/rapid test for screening
- If A1 positive → Test 2 (A2): Different antigen/different principle
- If A2 positive → Test 3 (A3): Third assay with different principle
- All three positive = HIV positive
- If A1+A2 positive but A3 negative = Indeterminate → repeat testing after 14 days
- A1 negative = HIV negative
3. Western Blot (Confirmatory - not used in India as primary confirmatory):
- Detects antibodies to specific HIV proteins on nitrocellulose strips
- Positive: ≥2 bands including gp41, gp120/gp160 and p24 (WHO criteria)
4. HIV Viral Load (HIV RNA PCR):
- Quantifies HIV-1 RNA copies/mL plasma
- Uses RT-PCR or bDNA technique
- Used for: Monitoring treatment response, detecting acute HIV (window period), diagnosis in neonates
- Target for treatment success: Viral load <50 copies/mL (undetectable)
5. CD4 Count (T-cell subsets):
- Flow cytometry to count CD4+ T cells
- Used for: Staging, decision to start ART, monitoring treatment, opportunistic infection prophylaxis
- CD4 <200/µL = AIDS
6. p24 Antigen Test:
- Detects HIV p24 core antigen
- Positive during: Acute HIV (before antibodies), late AIDS (when antibodies fall)
- Incorporated in 4th generation combo ELISA
Window period:
- 1st generation (IgG ELISA): 6-8 weeks
- 3rd generation: 3-4 weeks
- 4th generation (combo): ~15-18 days
- PCR: 10-12 days
Opportunistic Infections in HIV/AIDS:
When CD4 <500/µL:
- Tuberculosis (most common OI in India)
- Herpes zoster (reactivation)
- Oral candidiasis (thrush)
- Kaposi's sarcoma (HHV-8)
When CD4 <200/µL (AIDS-defining):
- Pneumocystis jirovecii pneumonia (PCP) - most common OI in western countries
- Toxoplasma gondii encephalitis (CD4 <100)
- Cryptococcal meningitis (Cryptococcus neoformans)
- CMV retinitis/colitis (CD4 <50)
- Mycobacterium avium complex (MAC)
Opportunistic Parasitic (Protozoal) Infections:
- Toxoplasma gondii - cerebral toxoplasmosis (CD4 <100): ring-enhancing lesions on CT/MRI
- Cryptosporidium parvum - chronic profuse watery diarrhea
- Cyclospora cayetanensis - diarrhea
- Isospora belli (Cystoisospora belli) - diarrhea
- Microsporidium spp. - diarrhea, keratoconjunctivitis
- Leishmania donovani - visceral leishmaniasis (unusual dissemination)
- Giardia lamblia - more severe/prolonged diarrhea
Monitoring Progression of HIV:
-
CD4+ T cell count (absolute + percentage):
- Most important clinical marker
- Monitor every 3-6 months
- Guides when to start ART and OI prophylaxis
-
HIV Viral Load (Plasma HIV RNA):
- Best predictor of rate of disease progression
- High viral load = rapid progression
- Measured at baseline, 4-8 weeks after starting ART, then every 3-6 months
- Goal: <50 copies/mL
-
Clinical staging (WHO stages I-IV)
-
Other markers (less used):
- Beta-2 microglobulin
- Neopterin levels
- p24 antigen levels
Post-Exposure Prophylaxis (PEP) for HIV - NACO Guidelines:
Indications: Occupational (needle-stick, splash) or non-occupational (sexual assault) exposure to HIV-infected material
Risk assessment:
- High risk: Needle-stick with blood, deep injury, hollow-bore needle
- Lower risk: Mucous membrane or non-intact skin exposure
First Aid:
- Immediately wash wound with soap and water (do not squeeze)
- Flush mucous membranes with water
- Do NOT use bleach/caustic agents
PEP Regimen (NACO):
- TDF (Tenofovir) + 3TC (Lamivudine) + LPV/r (Lopinavir/ritonavir)
- Alternative: TDF + 3TC (Emtricitabine, FTC) + EFV (Efavirenz)
- Duration: 28 days
- Must be started within 72 hours (ideally within 2 hours; earlier = more effective)
- After 72 hours, PEP is not effective
Baseline HIV testing: Test exposed person at 0, 6 weeks, 3 months, 6 months
Q: Case - 40-year-old male with recurrent herpes zoster + HIV
a. Clinical condition: The patient has Herpes Zoster (shingles) in the context of HIV/AIDS. Tzanck smear showing ground glass cells (multinucleated giant cells with intranuclear inclusions) is characteristic of VZV/HSV infection. Leukopenia with lymphocytopenia and reactive HIV confirms immunosuppression.
b. Labeled diagram of HIV: (see structure described above - spherical, lipid envelope with gp120/gp41 spikes, conical p24 capsid, containing 2 copies of RNA + RT + integrase)
c. Lab diagnosis of HIV: As described above (NACO Strategy III - three sequential rapid tests)
d. Post-exposure prophylaxis (needle-stick injury per NACO): As described above - TDF+3TC+LPV/r for 28 days, start within 72 hours, baseline testing, follow-up serology
Q: Case - 35-year-old male, IV drug abuse, unexplained fever, weight loss, diarrhea, lymphadenopathy for 8 months
a. Most probable diagnosis: AIDS (HIV infection, advanced stage)
b. Pathogenesis: As described above - HIV depletes CD4+ T cells → progressive immunosuppression → susceptibility to opportunistic infections
c. Lab diagnosis with NACO guidelines: NACO Strategy III (three rapid tests A1, A2, A3) + CD4 count + viral load
d. Precautions for prevention:
- Universal precautions for healthcare workers
- Safe sex practices (condoms)
- Avoid sharing needles (needle exchange programs, harm reduction)
- Screening blood/blood products
- Prevention of mother-to-child transmission (PMTCT)
- Pre-exposure prophylaxis (PrEP): TDF+FTC daily for high-risk individuals
- Voluntary counseling and testing (VCT)
- NACO guidelines for linkage to care and ART
CHAPTER 6 - VIRAL HEMORRHAGIC FEVER
Q: Classify arboviruses. General properties. Arboviruses in India. Diagnosis.
Classification of Arboviruses:
Arbovirus = Arthropod-Borne Virus (transmitted by arthropods like mosquitoes, ticks, sandflies)
Family Togaviridae:
- Genus Alphavirus: Chikungunya, Eastern/Western/Venezuelan equine encephalitis
Family Flaviviridae:
- Genus Flavivirus: Dengue, Yellow fever, Japanese encephalitis, West Nile virus, Zika virus, KFD (Kyasanur Forest Disease)
Family Bunyaviridae (now reclassified):
- Genus Phlebovirus: Sandfly fever
- Genus Nairovirus: Crimean-Congo hemorrhagic fever (CCHF)
- Genus Orthobunyavirus: La Crosse encephalitis
Family Reoviridae:
- Genus Orbivirus: Colorado tick fever
General Properties of Arboviruses:
- RNA viruses
- Enveloped (except reoviruses)
- Transmitted by arthropod vectors (mosquitoes, ticks, sandflies)
- Zoonotic - maintained in animal reservoir (birds, rodents) + arthropod cycle
- Humans are incidental (dead-end) hosts
- Can cause fever, encephalitis, hemorrhagic fever
Arboviruses in India:
- Dengue virus (DENV 1-4) - Aedes aegypti mosquito
- Chikungunya virus (CHIKV) - Aedes aegypti, A. albopictus
- Japanese Encephalitis virus (JEV) - Culex tritaeniorhynchus
- Kyasanur Forest Disease virus (KFDV) - Haemaphysalis ticks (hard ticks)
- West Nile virus - Culex mosquitoes
- Zika virus - Aedes mosquitoes
Q: Dengue Virus / Dengue Fever / Dengue Hemorrhagic Fever
Causative agent: Dengue virus - 4 serotypes (DENV-1, 2, 3, 4); Flavivirus family
Vector: Aedes aegypti (primary), A. albopictus (secondary) - day-biting mosquitoes
Reservoir: Humans (urban cycle); monkeys (sylvatic cycle)
Pathogenesis:
1. Viral infection: Dengue virus replicates in dendritic cells/macrophages after mosquito bite → viremia
2. Primary dengue (1st infection with any serotype):
- Mild disease; serotype-specific immunity develops
3. Secondary dengue (2nd infection with different serotype):
- Antibody-Dependent Enhancement (ADE): Non-neutralizing antibodies from 1st infection facilitate enhanced uptake of 2nd serotype into macrophages (via Fc receptors)
- Massive viral replication in macrophages → high viremia
- Cytokine storm (TNF-α, IL-1, IL-6) → increased vascular permeability, thrombocytopenia
4. DHF/DSS: Plasma leakage from capillaries due to cytokines → hemoconcentration, pleural effusion, ascites, circulatory collapse (Dengue Shock Syndrome)
Clinical Manifestations:
Classic Dengue Fever (DF):
- Incubation: 4-10 days
- High fever (biphasic/"saddle-back"), severe headache, retro-orbital pain
- "Breakbone fever" - severe myalgia and arthralgia
- Maculopapular rash (4th-5th day, "islands of white in sea of red")
- Positive tourniquet test
Dengue Hemorrhagic Fever (DHF) - WHO Grade I-IV:
- Grade I: Fever + positive tourniquet test
- Grade II: Grade I + spontaneous hemorrhage
- Grade III: Grade II + circulatory failure (narrowing pulse pressure, hypotension)
- Grade IV: Profound shock (undetectable pulse/BP) = Dengue Shock Syndrome (DSS)
Complications:
- Dengue Shock Syndrome (DSS)
- Hepatitis/hepatic failure
- Encephalitis/encephalopathy
- Myocarditis
- Acute respiratory distress syndrome (ARDS)
- Secondary bacterial infections
Laboratory Diagnosis:
Based on phase of illness:
Day 1-5 (Febrile phase/Acute phase) - VIREMIC:
- NS1 Antigen test (Non-structural protein 1): Rapid immunochromatographic test; very sensitive in early disease (day 1-5); specificity 100%
- RT-PCR: Detects dengue RNA; gold standard for acute phase; serotype identification
Day 5 onwards (Defervescence phase) - SEROLOGICAL:
- IgM antibody (MAC-ELISA): Detects IgM; positive from day 4-5 after fever onset
- Primary dengue: IgM appears earlier, higher levels
- Secondary dengue: IgM lower, IgG higher (IgG rises much faster = "secondary response")
- IgG antibody: IgG >1280 in acute phase suggests secondary dengue
- Dengue IgM/IgG ratio: IgM:IgG <1.2 = secondary dengue
- Haemagglutination inhibition (HI) test: 4-fold rise between acute and convalescent sera
Other tests:
- CBC: Leukopenia (WBC <5000), thrombocytopenia (<100,000 = DHF), rising hematocrit (>20% rise = plasma leakage)
- NS1+IgM combo rapid test
Q: Case - 29-year-old female with high fever, joint pain, petechial rashes, jaundice, hepatosplenomegaly, low platelets (30,000), positive tourniquet test
a. Clinical diagnosis and transmission:
- Dengue Hemorrhagic Fever (DHF)
- Transmitted by bite of Aedes aegypti mosquito (day-biting)
b. Pathogenesis: ADE in secondary dengue → cytokine storm → plasma leakage + thrombocytopenia + hemorrhage (as described above)
c. Confirm diagnosis:
- Acute phase (day 1-5): NS1 antigen test + RT-PCR
- After day 5: Dengue IgM ELISA
- CBC: Thrombocytopenia, leukopenia, rising hematocrit
d. Complications: DSS, hepatitis, encephalopathy, myocarditis, ARDS
Q: Kyasanur Forest Disease (KFD)
Causative agent: KFD virus - Flaviviridae, closely related to Omsk Hemorrhagic Fever and Russian Spring-Summer Encephalitis
Vector: Hard ticks - Haemaphysalis spinigera (primary vector); also other Haemaphysalis species
Reservoir: Small rodents, monkeys; ticks (transstadial transmission)
Geographic distribution: Endemic to Karnataka (Kyasanur Forest area) - originally described in 1957; now also in Kerala, Goa, Tamil Nadu, Karnataka
Hosts: Monkeys (dead-end hosts - mass mortality signals outbreak), humans (accidental hosts)
Clinical Features:
- Incubation: 3-8 days
- Biphasic illness:
- Phase 1: Abrupt onset of high fever, severe headache, myalgia, bradycardia, conjunctival congestion; hemorrhagic manifestations (epistaxis, hematemesis)
- Brief remission (7-21 days)
- Phase 2 (in ~50%): Neurological manifestations (meningoencephalitis - tremors, mental disturbance, vision disturbances)
- Leukopenia, thrombocytopenia, elevated liver enzymes
- Mortality: 3-5%
Lab Diagnosis:
- RT-PCR (acute phase)
- IgM and IgG ELISA (serology)
- Virus isolation (BSL-4 required)
- CBC: Leukopenia, thrombocytopenia
Prevention: Tick repellents, protective clothing; KFDV vaccine (inactivated, tissue culture-derived) - available and used in endemic areas of Karnataka
Q: Ebola Virus / Ebola Virus Diagnosis
Classification: Filovirus (family Filoviridae); genus Ebolavirus; 5 species: Zaire (most lethal), Sudan, Bundibugyo, Taï Forest, Reston
Morphology:
- Filamentous (pleomorphic) virus; can appear as U-shaped, 6-shaped, branching forms
- Non-segmented, negative-sense single-stranded RNA (-ssRNA)
- Enveloped; ~80 nm diameter, variable length
Geographic distribution: Sub-Saharan Africa (DRC, Guinea, Sierra Leone, Liberia)
Reservoir: Fruit bats (Pteropodidae family) - probable natural reservoir; monkeys, apes are amplifying hosts
Transmission:
- Direct contact with blood, secretions, organs, body fluids of infected humans or animals
- Nosocomial transmission (healthcare workers without PPE)
- Preparation of bushmeat ("hunting hypothesis")
- Sexual transmission (survivors can shed virus in semen for months)
- NOT airborne under natural conditions
Pathogenesis:
- Infects monocytes, macrophages, dendritic cells → systemic spread
- Massive cytokine storm → multiorgan failure
- Disseminated intravascular coagulation (DIC)
- Endothelial damage → hemorrhage
Clinical Features (Ebola Virus Disease - EVD):
- Incubation: 2-21 days (average 8-10 days)
- Sudden onset: Fever, severe headache, myalgia, weakness
- Vomiting, diarrhea
- Hemorrhagic phase: Bleeding from multiple sites, petechiae, ecchymoses
- Impaired kidney and liver function
- Mortality: 50-90%
Lab Diagnosis:
- RT-PCR (gold standard): Detects Ebola RNA; highly sensitive from day 3 of symptoms
- Antigen detection ELISA
- IgM/IgG ELISA (from day 7)
- Electron microscopy: Characteristic filamentous morphology
- ALL specimens must be handled at BSL-4
Treatment: Supportive; Zmapp (monoclonal antibody cocktail); Remdesivir; Ervebo (rVSV-ZEBOV) - approved vaccine for Zaire Ebola
Q: Chikungunya Fever
Causative agent: Chikungunya virus (CHIKV) - Togaviridae, genus Alphavirus
Vector: Aedes aegypti and A. albopictus (tiger mosquito - important in India/Europe)
Reservoir: Monkeys, rodents; humans (urban epidemic cycle)
Clinical Features:
- Incubation: 1-12 days (average 2-4 days)
- Sudden-onset high fever
- Severe, incapacitating joint pain (arthralgia/arthritis) - "Chikungunya" = "that which bends up" in Makonde language
- Joint swelling, morning stiffness
- Maculopapular rash
- Headache, myalgia
- Chronic arthritis can persist for months-years (distinguishes from dengue)
- Hemorrhage is RARE (unlike dengue)
Lab Diagnosis:
- Acute phase (day 1-5): RT-PCR (most sensitive); Virus isolation
- Day 5 onwards: IgM ELISA (MAC-ELISA); IgM positive for months
- Rapid ICT tests for IgM
Treatment: Symptomatic (NSAIDs/chloroquine for arthritis); no specific antiviral
Q: Lassa Fever
Causative agent: Lassa virus - Arenaviridae family; ambisense ssRNA
Reservoir: Mastomys natalensis (multimammate rat) - the natural reservoir; rodent sheds virus in urine and feces chronically without illness
Geographic distribution: West Africa (Nigeria, Sierra Leone, Guinea, Liberia) - endemic
Transmission:
- Contact with food/household items contaminated with rat urine/feces
- Eating infected rats (considered a delicacy)
- Person-to-person: Direct contact with blood/body fluids
- Nosocomial transmission
Clinical Features:
- Incubation: 6-21 days
- Gradual onset: Fever, malaise, headache
- Pharyngitis (exudative), chest pain, vomiting, diarrhea, abdominal pain
- Facial edema
- Hemorrhagic manifestations in severe cases (<20%)
- Deafness (sensorineural - major complication even after recovery)
- High mortality in pregnancy (~87% in 3rd trimester)
- Overall mortality: ~1%; hospitalized: 15-25%
Lab Diagnosis:
- RT-PCR (gold standard - acute)
- Antigen detection ELISA
- IgM/IgG ELISA
- BSL-4 handling required
Treatment: Ribavirin (IV) is effective - reduces mortality if given early in illness
CHAPTER 7 - MALARIA AND BABESIOSIS
Q: Parasites found in blood (hemoparasites)
- Plasmodium spp. (malaria) - inside RBCs
- Babesia spp. (babesiosis) - inside RBCs
- Trypanosoma spp. (T. brucei, T. cruzi) - in blood/plasma
- Leishmania donovani - inside monocytes/macrophages
- Microfilariae (Wuchereria bancrofti, Brugia malayi, Loa loa) - in blood
- Toxoplasma gondii - in blood (during acute parasitemia)
Plasmodia infecting man (4 classical + 1 zoonotic):
- Plasmodium falciparum - malignant tertian malaria (most dangerous)
- Plasmodium vivax - benign tertian malaria (most common worldwide)
- Plasmodium ovale - ovale tertian malaria
- Plasmodium malariae - quartan malaria
- Plasmodium knowlesi - zoonotic (from macaque monkeys in Southeast Asia)
Q: Life cycle, pathogenesis, lab diagnosis of P. falciparum
Life Cycle:
In Mosquito (Sexual cycle - Sporogony):
- Female Anopheles mosquito takes blood meal from infected human → ingests gametocytes
- In mosquito midgut: Microgametes and macrogametes fuse → zygote → ookinete → oocyst
- Oocyst ruptures → releases sporozoites
- Sporozoites migrate to salivary glands
In Human (Asexual cycle):
A. Exo-erythrocytic cycle (Liver/Pre-erythrocytic stage):
- Mosquito injects sporozoites into human bloodstream
- Sporozoites travel to liver within 30 minutes
- Invade hepatocytes → differentiate into trophozoites → schizonts
- Each schizont releases merozoites (hepatic/exo-erythrocytic merozoites)
- P. falciparum and P. malariae: NO dormant liver stage (no hypnozoites)
- P. vivax and P. ovale: Form hypnozoites (dormant liver stage) → responsible for relapses
B. Erythrocytic cycle:
- Hepatic merozoites invade RBCs → form ring trophozoite
- Ring → growing trophozoite → mature trophozoite (ameboid)
- Schizogony (nuclear division): Schizont forms containing merozoites
- RBC ruptures → merozoites released → invade new RBCs (cycle repeats)
- Cycle period: P. falciparum = 48 hours (malignant tertian fever every 48 hours)
P. falciparum unique features:
- Invades RBCs of ALL ages (young and old)
- Infected RBCs express knobs (PfEMP1) → cytoadherence to endothelium
- Sequestration in deep organs (brain, placenta, lung) → NOT seen in peripheral smear
- Only ring forms and crescentic/banana-shaped gametocytes seen in peripheral blood
- High parasitemia possible (>10%)
Pathogenesis of P. falciparum:
-
Fever: Merozoite release + pyrogens (GPI anchors, hemozoin) → stimulate cytokine release (IL-1, IL-6, TNF-α)
-
Anemia (multifactorial):
- Direct lysis of parasitized RBCs
- Destruction of non-parasitized RBCs (bystander hemolysis)
- Dyserythropoiesis (bone marrow suppression)
- Spleen hyperactivity
-
Cytoadherence and sequestration (P. falciparum SPECIFIC):
- Infected RBCs express PfEMP1 (P. falciparum Erythrocyte Membrane Protein 1) on surface knobs
- PfEMP1 binds ICAM-1 (cerebral vessels), CD36, CSA (placenta)
- Leads to sequestration in deep capillaries → microvascular obstruction → organ damage
-
Cerebral malaria:
- Sequestration in cerebral vessels → impaired blood flow
- Cytokine-mediated BBB disruption
- Coma, seizures
-
Placental malaria:
- PfEMP1 binds CSA (chondroitin sulfate A) in placenta → low birth weight, maternal anemia
-
Blackwater fever: Massive intravascular hemolysis → hemoglobinemia, hemoglobinuria (dark urine) → acute tubular necrosis, renal failure
Complications of Falciparum Malaria:
- Cerebral malaria (most dangerous): Coma, seizures, mortality >20%
- Blackwater fever: Hemolytic crisis → hemoglobinuria (black/dark urine)
- Severe anemia (<5 g/dL Hb)
- Acute renal failure
- ARDS (pulmonary edema)
- Hypoglycemia (especially in pregnant women on quinine)
- Thrombocytopenia
- Algid malaria (septic shock-like picture)
- Hyperpyrexia (>41°C)
- Splenic rupture
Life Cycle of P. vivax
Similar to P. falciparum except:
- P. vivax invades only young RBCs (reticulocytes)
- Schüffner's dots visible in infected RBCs (not in P. falciparum)
- Infected RBCs are enlarged
- Forms hypnozoites in liver → responsible for relapses (not recrudescence)
- Fever cycle: 48 hours (benign tertian)
- Gametocytes are round (not crescent-shaped)
- Less severe disease; cerebral malaria and blackwater fever are rare
Laboratory Diagnosis of Malaria:
1. Peripheral Blood Smear (Gold Standard):
- Thick smear: Screening; more sensitive; concentrates parasites; cells lysed
- Thin smear: Species identification; morphological features better preserved; stained with Giemsa or Leishman stain
Giemsa stain features:
| Feature | P. falciparum | P. vivax |
|---|
| Ring trophozoite | Delicate rings, often 2 nuclei, appliqué/accole position | Larger, irregular ameboid |
| Schüffner's dots | ABSENT | PRESENT (stippling in enlarged RBC) |
| RBC size | Normal or smaller | Enlarged |
| Gametocytes | Crescentic/banana-shaped | Round/oval |
| Mature schizonts | Rare in peripheral blood (sequestered) | Present |
| Merozoites per schizont | 8-24 | 12-24 |
2. Rapid Diagnostic Tests (RDTs):
- Immunochromatographic tests (ICT)
- Detect parasite antigens:
- HRP-2 (Histidine-Rich Protein 2): P. falciparum specific
- pLDH (Parasite Lactate Dehydrogenase): All species
- Aldolase: Pan-malarial
- Results in 15-20 minutes; no microscope needed
- Cannot determine parasitemia level
3. Quantitative Buffy Coat (QBC) fluorescence microscopy:
- Blood tube with acridine orange (fluorescent dye) + hematocrit centrifugation
- Parasites fluoresce bright orange/green
- More sensitive than thick smear
- Cannot easily identify species
4. Molecular methods (PCR):
- Most sensitive; species identification, drug resistance detection
- Not routine; used for research/reference labs
5. Serology (IFAT, ELISA):
- Detects antibodies; not useful for acute diagnosis (past exposure)
- Used for epidemiological surveys, blood donor screening
Q: Case - 23-year-old male, endemic area, intermittent fever with chills/rigors, intense sweating, splenomegaly, parasites inside RBCs on peripheral smear
a. Causative agent and vector:
- Causative agent: Plasmodium vivax (most likely given "endemic area" + typical tertian pattern)
- Vector: Female Anopheles mosquito (night-biting)
b. Life cycle: (as described above)
c. Pathogenesis: Erythrocytic schizogony → RBC rupture → fever, anemia, splenomegaly; cytokine release during merozoite release
d. Lab diagnosis: Peripheral blood smear (Giemsa/Leishman); RDT for pLDH; QBC; PCR
CHAPTER 8 - VISCERAL LEISHMANIASIS AND TRYPANOSOMIASIS
Q: Case - 31-year-old man from Bihar, splenomegaly, anemia, fever, bone marrow aspirate showing amastigotes in macrophages
a. Parasitic agent and clinical diagnosis:
- Parasite: Leishmania donovani
- Clinical diagnosis: Kala-azar (Visceral Leishmaniasis)
b. Life cycle:
In human host:
- Infected sandfly (Phlebotomus argentipes in India) bites human → injects promastigotes
- Promastigotes engulfed by macrophages in skin/RES
- Within macrophages, promastigotes transform into amastigotes (Leishman-Donovan bodies/LD bodies)
- Amastigotes multiply intracellularly by binary fission
- Macrophage ruptures → amastigotes infect new macrophages, spread to spleen, liver, bone marrow
In sandfly:
- Sandfly bites infected human → ingests amastigotes with blood meal
- In sandfly midgut: Amastigotes → promastigotes (flagellated, extracellular)
- Promastigotes multiply, migrate to proboscis
- Ready for injection into next host during blood meal
c. Diagnostic modalities:
1. Demonstration of LD bodies (Definitive diagnosis):
- Bone marrow aspirate (BMA): Most common clinical specimen; sensitivity 70-90%
- Splenic aspirate: Most sensitive (95-99%) but risk of hemorrhage (done only by specialists)
- Lymph node aspirate
- Liver biopsy
- Peripheral blood (rarely positive)
- Stain: Giemsa or Leishman stain
- LD bodies (amastigotes): 2-3 µm oval organisms inside macrophages; nucleus + kinetoplast (rod-shaped) visible (two distinct dots - "double dot" appearance)
2. Culture:
- NNN (Novy-MacNeal-Nicolle) medium - biphasic medium (agar base overlaid with Locke's/Defibrinated rabbit blood saline)
- Aspirate inoculated → promastigotes appear (motile flagellates)
- Incubated at 22-25°C
3. Animal inoculation:
- Hamster is the most susceptible experimental animal
- Intradermal/intracardiac inoculation → develop kala-azar features
4. Serology:
- DAT (Direct Agglutination Test): Detects IgG antibodies against whole promastigotes; titre ≥1:3200 diagnostic; used in field settings
- rK39 ICT rapid test (rK39 strip test): Most commonly used; detects IgG against rK39 antigen (conserved kinesin-related protein); sensitivity 90-100%; highly specific; results in minutes
- ELISA: Using soluble Leishmania antigen or rK39
- CFT (Complement Fixation Test): Classical Chopra's antimony test, largely replaced
- Leishmania formol-gel test (aldehyde test): Non-specific; 1 drop of 40% formaldehyde added to patient serum → coagulation/gelation in positive case; highly non-specific, historical interest only
5. Molecular methods:
- PCR on blood, bone marrow, or buffy coat
- More sensitive than microscopy, especially for immunocompromised patients
d. Treatment:
- First-line: Miltefosine (oral, 28 days) - first oral drug for kala-azar; used in India for VL
- Second-line/severe cases: Liposomal Amphotericin B (IV, 3-5 mg/kg/day for 3-5 doses) - highly effective, low toxicity
- Amphotericin B deoxycholate (conventional): Effective but more toxic
- Sodium stibogluconate (SSG/Pentostam): First-line in Africa and other regions; resistance in India limits use
- Miltefosine + Amphotericin B: Combination therapy in drug-resistant cases
Q: LD bodies (Draw and label)
LD body (Leishman-Donovan body) = Amastigote form of Leishmania donovani
Morphology:
- Small (2-3 µm), oval/round organisms
- Found inside macrophages (intracellular)
- On Giemsa stain:
- Nucleus: Large, round, stains red-purple
- Kinetoplast: Small, rod-shaped, stains deeply purple; located adjacent to nucleus - gives characteristic "double dot" or "shepherd's crook" appearance
- Cytoplasm: pale blue/lavender
- Groups of LD bodies pack the cytoplasm of macrophages
Q: Post-Kala-Azar Dermal Leishmaniasis (PKDL)
Definition: PKDL is a dermatological complication that occurs after treatment of visceral leishmaniasis (kala-azar), characterized by skin lesions.
Occurrence:
- India: 5-10% of kala-azar patients develop PKDL, typically 6 months to 3 years after apparent cure of VL
- Sudan: 50% of kala-azar patients; occurs during or shortly after treatment
Clinical features:
- Starts as hypopigmented or erythematous macules on the face (especially around nose and mouth)
- Progresses to papules, nodules (resembling lepromatous leprosy)
- Skin lesions contain L. donovani amastigotes
- Patients are NOT systemically ill (no fever, no splenomegaly)
Significance:
- PKDL patients act as a reservoir of infection → continue transmission of kala-azar
- Important source during inter-epidemic periods
Diagnosis:
- Skin slit-smear for LD bodies
- Skin biopsy → Giemsa stain
- PCR on skin tissue
- rK39 serology
Treatment: Miltefosine for 12 weeks; Amphotericin B
Q: Chagas Disease
Causative agent: Trypanosoma cruzi
Vector: Reduviid bugs (triatomine bugs, "kissing bugs") - Triatoma infestans (most important), Rhodnius prolixus
Mechanism of transmission:
- Bug bites → defecates on skin while feeding → feces with trypomastigotes are rubbed into bite wound or conjunctiva by scratching
- NOT through the bite itself
Geographic distribution: Latin America (South and Central America)
Life cycle:
- Amastigotes in host cells (heart, skeletal muscle) → trypomastigotes in blood → ingested by bug → multiply → metacyclic trypomastigotes in bug hindgut
Clinical features:
- Acute Chagas disease: Romaña's sign (painless unilateral periorbital edema when entry is conjunctiva), chagoma (skin lesion), fever, lymphadenopathy
- Chronic Chagas disease (years later):
- Chagas cardiomyopathy (most serious): Dilated cardiomyopathy, arrhythmias, sudden death
- Chagasic megacolon and megaesophagus (destruction of enteric neurons)
Lab Diagnosis:
- Acute: Wet blood film → motile trypomastigotes; Blood smear (Giemsa) → trypomastigotes with C-shape/U-shape
- Xenodiagnosis: Uninfected lab-reared bugs fed on patient → bugs examined for trypanosomes
- Chronic: Serology (ELISA, IFA, indirect hemagglutination)
Q: Classify Leishmaniasis
| Type | Species | Disease | Vector | Geographic Distribution |
|---|
| Visceral (VL/Kala-azar) | L. donovani | Kala-azar, PKDL | Phlebotomus argentipes (sandfly) | India, Bangladesh, Nepal, East Africa |
| L. infantum/chagasi | VL in children | Phlebotomus/Lutzomyia | Mediterranean, Latin America |
| Cutaneous (CL) | L. tropica | Oriental sore (dry type) | P. sergenti | Mediterranean, Middle East |
| L. major | Rural cutaneous (wet type) | P. papatasi | Africa, Middle East, Central Asia |
| L. aethiopica | CL, DCL | P. longipes | East Africa |
| Mucocutaneous (MCL) | L. braziliensis | Espundia (naso-oral destruction) | Lutzomyia sandfly | South America |
| Diffuse cutaneous (DCL) | L. aethiopica, L. amazonensis | Widespread non-ulcerating nodules | Various | Africa, South America |
Q: NNN Medium
Full name: Novy-MacNeal-Nicolle medium
Type: Biphasic medium (solid phase + liquid phase)
Composition:
- Solid base: Agar with 2N NaCl (saline agar)
- Liquid overlay: Defibrinated rabbit blood (or blood saline - Locke's solution) added after autoclaving and cooling the agar
Use: Cultivation of Leishmania and Trypanosoma promastigotes/epimastigotes from clinical specimens
Procedure:
- Aspirate (bone marrow/spleen) inoculated into the liquid phase
- Incubated at 22-24°C (optimal for promastigote stage)
- Examined weekly for motile promastigotes (flagellated forms)
Result (positive): Promastigotes appear as elongated, flagellated motile organisms
Q: Serological Tests for Kala-Azar
- rK39 ICT (Rapid test): Most widely used; strip test detecting IgG to rK39; sensitivity/specificity >90%; point-of-care
- DAT (Direct Agglutination Test): Titre ≥1:3200; sensitive, field-friendly but requires cold chain
- ELISA: Using rK39, rKE16 or whole antigen; quantitative
- Formol-gel (aldehyde) test: Historical; non-specific; coagulation of serum with formaldehyde - replaced by specific tests
- CFT (Complement Fixation Test): Chopra's reaction - historical interest
CHAPTER 9 - LYMPHATIC FILARIASIS
Q: Classify filariasis. Pathogenesis and lab diagnosis of lymphatic filariasis.
Classification of Filariasis:
| Type | Species | Location in body | Vector | Periodicity of MF |
|---|
| Lymphatic filariasis | Wuchereria bancrofti | Lymphatics | Culex quinquefasciatus | Nocturnal periodic |
| Brugia malayi | Lymphatics | Mansonia spp. | Nocturnal periodic/subperiodic |
| Brugia timori | Lymphatics | Anopheles barbirostris | Nocturnal periodic |
| Subcutaneous filariasis | Loa loa | Skin/eye | Chrysops (deerfly) | Diurnal |
| Mansonella streptocerca | Skin | Culicoides midges | Non-periodic |
| Serous cavity filariasis | Mansonella perstans | Body cavities | Culicoides midges | Non-periodic |
| Ocular/Skin | Onchocerca volvulus | Skin, eye | Simulium (blackfly) | Non-periodic |
Wuchereria bancrofti - Pathogenesis and Lab Diagnosis:
Causative agent: Wuchereria bancrofti; adult worms live in lymphatics
Vector: Culex quinquefasciatus (night-biting mosquito) in India
Life cycle:
- Mosquito bites → deposits L3 (infective/filariform larvae) on skin → larvae enter through puncture wound
- L3 → L4 → adult worms in lymphatic vessels/lymph nodes (mature in ~12 months)
- Adult worms (male + female): Male 4 cm, female 8-10 cm
- Female produces microfilariae (L1 larvae)
- Microfilariae enter bloodstream - nocturnal periodicity (in peripheral blood maximally between 10 PM - 2 AM in Indian strain)
- Mosquito ingests microfilariae during night blood meal → develop to L3 in flight muscles → migrate to proboscis
Pathogenesis:
Acute phase:
- Living worms in lymphatics → lymphangitis (retrograde - from distal to proximal; characteristic of filariasis; unlike bacterial lymphangitis which is proximal to distal)
- Lymphadenitis
- Fever, scrotal pain, epididymo-orchitis
Chronic phase (due to immune response + death of adult worms):
- Lymphatic obstruction → dilatation of lymphatics → lymphedema
- Chronic lymphedema of legs → elephantiasis (thickened, fibrotic skin)
- Lymphedema of scrotum → hydrocele (most common manifestation in males)
- Lymphedema of breast, arm
- Chyluria: Rupture of dilated lymphatics into urinary tract → milky white urine (lymph + urine)
- Tropical Pulmonary Eosinophilia (TPE): Microfilariae trapped in lungs → eosinophilic response; cough, wheeze, high eosinophilia
Laboratory Diagnosis:
1. Demonstration of microfilariae (DEFINITIVE):
- Nocturnal blood collection (10 PM - 2 AM) - essential due to nocturnal periodicity
- Thick blood smear: Most commonly used; Giemsa/Leishman stain; look for sheathed microfilariae
- Knott's concentration technique: 1 mL blood + 9 mL of 2% formalin → centrifuge → examine sediment; increases sensitivity 6-7 fold
- Membrane filtration (Millipore filter): Most sensitive
2. DEC (Diethylcarbamazine) Provocation Test:
- Administered during daytime when MF are not in peripheral blood
- DEC 50-100 mg orally → microfilariae appear in peripheral blood within 30-60 minutes (provocation)
- Daytime blood sample collected 20-60 minutes after DEC
- Used for: Detecting occult infections, confirming periodicity in atypical cases
3. Nocturnal microfilaremia test (night blood): Standard method
4. Antigen detection:
- Og4C3 ELISA / ICT (Immunochromatographic card test): Detects circulating filarial antigen (CFA) of W. bancrofti
- ICT filariasis test: Positive even in daytime (not affected by periodicity)
- Very sensitive and specific; no need for night blood collection
5. Serology: ELISA for IgG4 antibodies (sensitive but not species-specific)
6. Imaging:
- Ultrasonography (scrotal USG): "Filarial dance sign" - live adult worms visible as moving hyperechoic spots in dilated lymphatics
7. PCR: Detection of W. bancrofti DNA in blood
Q: Microfilaria
- Microfilaria = L1 larval stage produced by adult female filarial worms
- Circulate in peripheral blood (for W. bancrofti, B. malayi) or in skin (Onchocerca)
- W. bancrofti microfilaria:
- Sheathed (covered in egg membrane)
- Nocturnal periodic (maximal 10PM-2AM)
- No nuclei in tail tip (useful for species ID)
- 244-296 µm long
- B. malayi microfilaria:
- Sheathed
- Has nuclei in tail tip (two discrete subterminal nuclei)
- Nocturnal periodic
Q: Chyluria
Definition: Presence of chyle (lymph containing fat/triglycerides) in urine, giving it a milky white, opalescent appearance.
Cause in filariasis:
- Adult worms cause lymphatic obstruction → lymphatics dilate and rupture into renal pelvis/calyx or urinary tract
- Lymph (chyle) enters urine → milky white urine
Other causes: Tuberculosis, malignancy, trauma, congenital
Diagnosis:
- Urinalysis: Milky/turbid urine
- Sudan III/IV staining of urine: Stains fat droplets
- Urine becomes clear on adding ether (fat dissolves)
- Microfilariae may be seen in urine centrifuge sediment
- Lymphangiography
Q: DEC (Hetrazan) Provocation Test
DEC = Diethylcarbamazine citrate (Hetrazan)
Principle: DEC drives sequestered nocturnal microfilariae from the pulmonary capillaries (where they are during daytime) into peripheral circulation.
Procedure:
- Patient is daytime (9 AM-5 PM)
- Baseline daytime blood smear taken (usually negative)
- DEC 50-100 mg given orally (or 2-6 mg/kg)
- Blood collected after 20-60 minutes
- Thick blood smear prepared and examined for microfilariae
Positive result: Microfilariae visible in peripheral blood smear after DEC administration
Uses:
- Diagnosis of occult filariasis (microfilaremia too low for routine detection)
- Diagnosing filariasis when only daytime blood samples are possible
- Confirmation of nocturnal periodicity
Note: DEC can also cause adverse reactions (Mazzotti-like reaction) especially if there is high microfilaremia.
CHAPTER 10 - SYSTEMIC CANDIDIASIS AND SYSTEMIC MYCOSES
Q: Candida albicans / Candidiasis - morphology, pathogenicity, lab diagnosis
Morphology:
- Dimorphic fungus: Exists as yeast AND hyphae/pseudohyphae
- Yeast form: Oval, thin-walled, 3-6 µm; reproduce by budding (blastoconidia/blastospores)
- Pseudohyphae: Elongated yeast cells that remain attached, forming chains with constrictions at septa (not true hyphae)
- True hyphae: Also produced (especially in tissue invasion)
- Chlamydoconidia (chlamydospores): Large, thick-walled, round spores at terminal or intercalary positions in pseudohyphae; unique to C. albicans; formed in nutrient-deficient conditions at 25°C; seen on corn meal agar with Tween 80
Pathogenicity (Infections caused):
A. Superficial/Mucosal Candidiasis:
- Oral candidiasis (Thrush): White curd-like plaques on oral mucosa; bleeds on scraping; common in immunocompromised, neonates, elderly
- Vulvovaginal candidiasis: Thick white "cottage-cheese" discharge; itching; common in diabetics, pregnant, antibiotics
- Cutaneous candidiasis: Intertrigo (in skin folds), diaper rash, paronychia
- Esophageal candidiasis: AIDS-defining illness; painful swallowing (odynophagia)
B. Invasive/Systemic Candidiasis:
- Candidemia (bloodstream infection): Most common life-threatening; intravascular catheters major risk
- Hepatosplenic candidiasis: In neutropenic patients
- Renal candidiasis: Hematogenous
- Candida endocarditis: Especially in IV drug users, prosthetic valves
- Candida meningitis
- Ophthalmic candidiasis: Endophthalmitis
Risk factors for systemic candidiasis: Prolonged broad-spectrum antibiotics, immunosuppression, neutropenia, central venous catheters, TPN, diabetes, steroid use, HIV/AIDS
Laboratory Diagnosis:
1. Direct Microscopy:
- Specimen: Swab, scrapings, sputum, CSF, blood, BAL
- KOH mount (10-20% KOH): Reveals yeast cells, pseudohyphae, budding - rapid, easy
- Gram stain: Candida stains gram-positive (yeast forms appear as oval budding cells)
- Calcofluor white stain (fluorescence): Highly sensitive for fungal elements
2. Culture:
- Sabouraud Dextrose Agar (SDA): Growth at 37°C (and 25°C) within 24-48 hours
- Cream-colored, smooth, pasty colonies (characteristic smell - yeasty)
- Blood culture (automated - BacT/ALERT): For candidemia
3. Germ Tube Test (Reynolds-Braude phenomenon):
- Most important presumptive identification test for C. albicans
- Principle: C. albicans produces germ tubes (short filamentous extensions from yeast cells WITHOUT a constriction at the point of origin) when incubated in human/horse serum at 37°C for 2-3 hours
- Procedure:
- Yeast colony suspended in 0.5 mL human serum
- Incubated at 37°C for 2-3 hours
- Wet mount examined under microscope
- Positive: Germ tubes (slender, cylindrical filaments about 3× length of yeast cell, no constriction at base)
- Positive species: C. albicans (and C. dublinensis)
- Negative: Other Candida species (C. tropicalis, C. parapsilosis, etc.)
4. Chlamydoconidia formation:
- On Corn meal agar with Tween 80 at 25°C after 48-72 hours
- C. albicans produces chlamydospores (large, round, thick-walled terminal conidia)
- Unique to C. albicans; used for definitive identification
5. CHROMAGAR Candida:
- Differential chromogenic medium
- C. albicans → green colonies
- C. tropicalis → dark blue/metallic blue
- C. krusei → purple with white edge
- Used for rapid speciation
6. Antigen/Antibody Tests:
- Beta-D-Glucan (1,3-β-D-glucan) assay: Detects pan-fungal cell wall antigen; elevated in invasive candidiasis; sensitive but not Candida-specific
- Mannan antigen and anti-mannan antibody (ELISA): For invasive candidiasis
7. Molecular methods:
- PCR from blood; highly sensitive
Treatment: Superficial - Fluconazole (oral); Topical azoles or nystatin
Invasive candidiasis - Echinocandins (caspofungin, micafungin - first-line for IC); Fluconazole; Amphotericin B
Q: Histoplasmosis / Histoplasma capsulatum - lab diagnosis
Causative agent: Histoplasma capsulatum var. capsulatum
Dimorphic fungus:
- Mold form (25°C): White fluffy colonies; produces macroconidia (thick-walled, tuberculate - "knobby") and microconidia
- Yeast form (37°C, in tissue): Small oval yeast cells (2-4 µm), found inside macrophages (similar to LD bodies but slightly larger and no kinetoplast)
Geographic distribution: Ohio and Mississippi River valleys (USA); also India, Africa, Latin America
Habitat: Soil contaminated with bird (pigeon, starling) or bat droppings
Route of infection: Inhalation of microconidia/hyphal fragments
Clinical forms:
- Asymptomatic
- Acute pulmonary histoplasmosis (flu-like)
- Chronic pulmonary histoplasmosis (mimics TB)
- Disseminated/progressive histoplasmosis (in immunocompromised/HIV)
Lab Diagnosis:
1. Direct microscopy:
- Bone marrow, BAL, blood, lymph node biopsy
- Wright/Giemsa stain: Small oval yeast cells inside macrophages
- GMS (Gomori Methenamine Silver) stain: Stains fungal cell walls black
2. Culture:
- SDA at 25°C (mold) and 37°C (yeast)
- Mold: White → brown colonies; tuberculate macroconidia (pathognomonic)
- BSL-3 organism - biohazard precautions required
- Growth takes 2-6 weeks
3. Serology:
- Complement Fixation Test (CFT): Anti-histoplasmin and anti-yeast antibodies; titre ≥1:32 significant
- Immunodiffusion (ID): Detects H and M precipitin bands; H band = active infection
- ELISA
4. Antigen detection:
- Histoplasma urinary antigen (MVista® ELISA): Most sensitive test; detects polysaccharide antigen in urine/serum; best for disseminated disease; monitor treatment response
- Sensitivity >90% in disseminated histoplasmosis
5. Histopathology:
- PAS or GMS stain on tissue sections
- Oval yeast within macrophages
6. PCR: Available in reference labs
Q: Coccidioidomycosis
Causative agent: Coccidioides immitis (USA) and C. posadasii (other regions)
Dimorphic fungus:
- Mold form (environmental/25°C): Produces arthroconidia (barrel-shaped; barrel and ghost cells alternate)
- Spherule (37°C in tissue): Large, thick-walled spherule (20-60 µm) filled with endospores (2-5 µm) - pathognomonic
Geographic distribution: Arid/semiarid regions: San Joaquin Valley (California), Arizona, Texas, Mexico, South America - "Valley Fever"
Habitat: Alkaline desert soil
Route of infection: Inhalation of arthroconidia (HIGHLY infectious)
Clinical forms:
- Primary pulmonary coccidioidomycosis (60% asymptomatic; 40% flu-like = "Valley fever")
- Disseminated coccidioidomycosis: Skin, bone, meninges; most serious; more common in dark-skinned individuals, immunocompromised
Lab Diagnosis:
1. Direct microscopy:
- Sputum, BAL, pus, CSF
- 10% KOH mount or calcofluor white: Reveals large spherules containing endospores - pathognomonic
- Papanicolaou (PAP) stain or H&E on tissue
2. Culture:
- SDA at 25°C → white cottony colonies (arthroconidia)
- EXTREME BIOHAZARD - BSL-3: Arthroconidia are easily aerosolized and highly infectious
- Growth in 1-2 weeks
3. Serology (most useful in coccidioidomycosis):
- IgM by immunodiffusion (ID) or tube precipitation: Positive early (1st 3 weeks); indicates primary/early infection
- IgG by CF (Complement Fixation Test): Indicates chronicity/dissemination; titre ≥1:32 suggests disseminated disease; used to monitor treatment
- Latex agglutination (LA): Rapid screening for IgM
4. Antigen detection: Not widely available
5. Molecular methods: PCR
Treatment: Mild - Fluconazole/Itraconazole; Severe/meningitis - Liposomal Amphotericin B + long-term fluconazole
Q: Germ Tube Test (Reynolds-Braude Phenomenon) - Describe
Definition: The Germ Tube Test (also called Reynolds-Braude test) is a simple, rapid identification test for Candida albicans.
Principle: C. albicans produces germ tubes (short hyphal outgrowths) when incubated in protein-rich medium (serum) at 37°C for 2-3 hours, due to stimulation of hyphal transformation.
Materials required:
- Human serum or horse serum (0.5 mL)
- Candida colony
- Microscope
Procedure:
- A small inoculum (1-2 colonies) of Candida is emulsified in 0.5 mL of human serum in a test tube
- Incubated at 37°C for 2-3 hours (not more than 3 hours - pseudohyphae formation can cause false positive)
- A drop of suspension placed on glass slide with coverslip
- Examined under light microscope (×400)
Positive Result (C. albicans):
- Germ tube = slender, elongated tube-like extension from yeast cell
- No constriction at origin (this differentiates from pseudohyphae which have constrictions)
- Length ~3× the diameter of yeast cell
- Represents early hyphal formation
Negative Result:
- No germ tube; yeast cells remain as oval buds
Species giving positive result: C. albicans and C. dubliniensis
Species giving negative result: C. tropicalis, C. parapsilosis, C. glabrata, C. krusei, C. lusitaniae
Importance:
- Rapid and cost-effective presumptive identification of C. albicans
- 97% sensitivity for C. albicans
- If positive, further tests (chlamydospore production, CHROMAGAR) confirm identification
I hope these comprehensive answers help you score well in your exam! All answers are sourced directly from your textbook (Micro CVS Blood TB). Key points to remember for writing in exams:
- Use headings and numbered/bulleted lists
- Write the bold key terms (organisms, test names, media names)
- For long essays (HIV, malaria, typhoid), follow the standard format: Definition → Causative agent → Pathogenesis → Clinical features → Lab diagnosis → Treatment
- For case-based questions (a, b, c, d), answer each sub-part clearly
Good luck with your exam! 🎯